Intradialytic Exercise, Symptoms, and Well-being in Hemodialysis Patients

November 12, 2026 updated by: Muş Alparslan University

The Effects of Intradialytic Aerobic Exercise on Dialysis-Related Symptoms and Well-being in Haemodialysis Patients: A Randomized Controlled Trial

**Study Summary**

Hemodialysis patients frequently experience a high burden of dialysis-related symptoms, including fatigue, muscle weakness, pain, sleep disturbances, pruritus, and psychological complaints. These symptoms may negatively affect daily functioning and overall well-being. Intradialytic exercise has been proposed as a feasible complementary intervention to improve health-related outcomes in this population, as it allows patients to engage in physical activity during their routine hemodialysis sessions.

This study aims to investigate the effects of intradialytic aerobic exercise on dialysis-related symptoms and subjective well-being in patients undergoing maintenance hemodialysis. A randomized controlled trial will be conducted involving patients receiving regular hemodialysis treatment. Participants will be randomly allocated to either an intervention group or a control group. The intervention group will perform intradialytic aerobic exercise using a pedal exercise device during hemodialysis sessions, while the control group will continue to receive standard hemodialysis care without an additional exercise intervention.

The intervention will be implemented over a six-week period, with exercise sessions conducted three times per week. Dialysis-related symptoms will be assessed using the Dialysis Symptom Index (DSI), while subjective well-being will be evaluated using the World Health Organization-Five Well-Being Index (WHO-5). Both outcome measures will be administered before and after the intervention.

The primary objective is to determine whether intradialytic aerobic exercise reduces dialysis-related symptom burden compared with standard care. The secondary objective is to evaluate its effects on subjective well-being. The findings are expected to provide further evidence regarding the potential role of intradialytic aerobic exercise as a practical intervention for improving patient-centered outcomes in individuals receiving maintenance hemodialysis.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Having received hemodialysis treatment for 4 hours a day, 3 days a week, for at least 3 months.

Exclusion Criteria:

  • Having a history of myocardial infarction within the last 3 months
  • Having angina pectoris or uncontrolled arrhythmia and uncontrolled hypertension
  • Having communication or cognitive problems to the extent that one cannot complete the required tests
  • Being pregnant or undergoing infertility treatment
  • Having a psychiatric diagnosis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: aerobic exercise

Participants assigned to this group will perform intradialytic aerobic exercise using a pedal ergometer while lying in a supine position during hemodialysis sessions. Exercise will be performed using the lower extremities for 20 minutes per session at a moderate intensity corresponding to 12-16 on the Borg Rating of Perceived Exertion Scale. The intervention will be conducted three times per week for 6 weeks during routine hemodialysis treatment. Participants will continue to receive standard hemodialysis care throughout the intervention.

The use of intradialytic aerobic exercise in hemodialysis patients.

No Intervention: control group

Participants assigned to the control group will receive routine hemodialysis treatment without any additional exercise intervention throughout the 6-week study period. No pedal ergometer exercise or other structured physical activity program will be provided as part of the study.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dialysis Symptom Index (DSI)
Time Frame: Baseline and 6 weeks.

Dialysis-related symptom burden will be assessed using the Dialysis Symptom Index (DSI), a 30-item instrument evaluating the presence and severity of physical and emotional symptoms experienced by hemodialysis patients. Higher total scores indicate a greater symptom burden. The change in DSI total score from baseline to the end of the 6-week intervention will be compared between the intervention and control groups.

Baseline and 6 weeks.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
World Health Organization-Five Well-Being Index (WHO-5)
Time Frame: Baseline and 6 weeks.

Subjective well-being will be assessed using the World Health Organization-Five Well-Being Index (WHO-5), a 5-item self-report questionnaire evaluating subjective psychological well-being over the previous two weeks. Total scores range from 0 to 100, with higher scores indicating better well-being. The change in WHO-5 total score from baseline to the end of the 6-week intervention will be compared between the intervention and control groups.

Baseline and 6 weeks.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Director: Cengiz TAŞKAYA, Muş Alparslan University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 30, 2026

Primary Completion (Estimated)

January 4, 2027

Study Completion (Estimated)

January 22, 2027

Study Registration Dates

First Submitted

November 12, 2026

First Submitted That Met QC Criteria

November 12, 2026

First Posted (Actual)

November 18, 2026

Study Record Updates

Last Update Posted (Actual)

November 18, 2026

Last Update Submitted That Met QC Criteria

November 12, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • Intradialytic Exercise

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.